Diabetic keratopathy: Insights and challenges.
S Priyadarsini1, A Whelchel2, S Nicholas1
1Department of Ophthalmology, Dean McGee Eye Institute, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Survey of Ophthalmology
|February 25, 2020
Summary
Diabetic keratopathy, a common diabetes complication, causes vision loss through corneal issues. Further research is needed to understand its causes and find effective treatments.
Area of Science:
- Ophthalmology
- Diabetology
- Corneal Science
Background:
- Diabetic keratopathy is a frequent ocular complication of diabetes mellitus.
- It is characterized by epithelial disturbances, potentially leading to vision loss.
- Clinical studies on its pathobiology and treatment are limited.
Purpose of the Study:
- To summarize clinical manifestations of diabetic keratopathy.
- To discuss current treatments for diabetic keratopathy.
- To review recent research on diabetic keratopathy.
Main Methods:
- Literature review of clinical studies and research on diabetic keratopathy.
- Synthesis of information on clinical signs and symptoms.
- Analysis of available therapeutic approaches.
Main Results:
- Diabetic keratopathy presents with persistent epithelial erosion, delayed healing, and reduced sensitivity.
- These manifestations can compromise visual acuity and lead to permanent vision loss.
- Understanding the pathobiology remains challenging due to limited research.
Conclusions:
- Diabetic keratopathy is a significant sight-threatening condition in diabetes patients.
- Effective therapeutic strategies are not yet well-established.
- Further research is crucial for better management and treatment options.
Related Concept Videos
01:20Pathophysiology of Diabetes
2.9K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.9K
01:25Glaucoma: Overview
1.1K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.1K
01:15Diabetes: Symptoms, Diagnosis, and Complications
1.9K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.9K
01:24Chronic Kidney Disease II: Clinical Manifestations
480
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
480
01:15Diabetes: Management and Pharmacotherapy
787
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
787
01:22Diabetes Mellitus: Overview and Type I Subtype
4.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.7K